`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`
`
`
`
`
`
`
`
`
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`
`
`
`
`
`
`
`
`
`
`
`INITIATIVE FOR MEDICINES, ACCESS & KNOWLEDGE (I-MAK), INC.
`Petitioner
`
`v.
`
`GILEAD PHARMASSET LLC
`Patent Owner
`
`
`
`
`
`
`
`
`
`
`
`
`Case IPR2018-00390
`Patent 8,889,159
`
`
`
`
`
`
`
`
`
`
`
`
`PATENT OWNER GILEAD PHARMASSET LLC’S
`MANDATORY NOTICES
`
`ActiveUS 166123392v.1
`
`
`
`Case IPR2018-00390
`Attorney Docket No: 2209539-00142
`
`
`
`
`
`PATENT OWNER’S MANDATORY NOTICES
`UNDER 37 C.F.R. § 42.8
`
`Pursuant to 37 C.F.R. § 42.8, the patent owner, Gilead Pharmasset LLC
`
`(“Patent Owner”), hereby submits the following Mandatory Notices in response to
`
`the Petition for Inter Partes Review of U.S. Patent No. 8,889,159.
`
`1.
`
`Real Party-In-Interest under 37 CFR § 42.8(b)(1)
`
`Gilead Pharmasset LLC is the Patent Owner and Gilead, Inc. is a Real Party-
`
`In-Interest in this proceeding.
`
`2.
`
`Related Matters under 37 CFR § 42.8(b)(2)
`
`The following judicial or administrative matters may affect or be affected by
`
`a decision in this proceeding:
`
`U.S. Patent Application Serial No. 15/410,438 filed 01/19/2017 (Pending)
`
`and U.S. Patent Application Serial No. 14/538,736 filed 11/11/2014 (now U.S.
`
`Patent No. 9,549,941).
`
`Patent Owner notes that Petitioner filed two petitions for Inter Partes Review
`
`of U.S. Patent No. 7,964,580 (Case Nos. IPR2018-00119 and IPR2018-00120);
`
`two petitions for Inter Partes Review of U.S. Patent No. 8,334,270 (Case Nos.
`
`IPR2018-00121 and IPR2018-00122), one petition for Inter Partes Review of U.S.
`
`Patent 7,429,572 (Case IPR2018-00103), one petition for Inter Partes Review of
`
`U.S. Patent 8,663,309 (Case IPR2018-00125), one petition for Inter Partes Review
`2
`
`ActiveUS 166123392v.1
`
`
`
`Case IPR2018-00390
`Attorney Docket No: 2209539-00142
`of U.S. Patent No. 9,284,342 (Case No. IPR2018-00126), and one petition for Inter
`
`Partes Review of U.S. Patent No. 9,393,256 (Case No. IPR2018-00211).
`
`Patent Owner does not concede that any of the above-identified patents,
`
`applications, or proceedings, aside from U.S. Patent No. 8,889,159 would affect, or
`
`be affected by this proceeding.
`
`3.
`
`Lead and Back-Up Counsel, under 37 CFR § 42.8(b)(3)
`
`The Patent Owner designates the following lead and back-up counsel:
`
`
`
`LEAD COUNSEL
`David L. Cavanaugh, Reg. No. 36,476
`1875 Pennsylvania Avenue, N.W.
`Washington, DC 20006
`Phone: 202 663 6025
`Fax: 202 663 6363
`Email:
`david.cavanaugh@wilmerhale.com
`
`
`
`
`ActiveUS 166123392v.1
`
`BACK-UP COUNSEL
`Emily R. Whelan, Reg. No. 50,391
`60 State Street
`Boston MA 02109
`Phone 617 526 6567
`Fax: 617 526 5000
`Email: emily.whelan@wilmerhale.
`
`Dorothy P. Whelan, Reg. No. 33,814
`3200 RBC Plaza
`60 South Sixth Street
`Minneapolis, MN 55402
`Tel: (612) 337-2509
`Email:
` PTABInbound@fr.com
`Fax:
`
`(612) 288-9696
`
`
`Michael J. Kane, Reg. No. 39,722
` 3200 RBC Plaza
`60 South Sixth Street
`Minneapolis, MN 55402
`Tel: (612) 337-2502
`Email:
`PTABInbound@fr.com
`Fax:
`
`(612) 288-9696
`3
`
`
`
`Case IPR2018-00390
`Attorney Docket No: 2209539-00142
`
`
`W. Chad Shear, Reg. No. 47,938
` 3200 RBC Plaza
`60 South Sixth Street
`Minneapolis, MN 55402
`Tel: (858) 678-4730
`Email:
`PTABInbound@fr.com
`Fax:
`
`(612) 288-9696
`
`
`Service Information under 37 CFR § 42.8(b)(4)(i) et seq.
`
`Please address all correspondence and service to both counsel as listed
`
`
`
`
`
`4.
`
`above. Patent Owner consents to service by email to the email addresses above
`
`(ref.: Docket No. 2209539-00142; Case IPR2018-00390).
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
` Respectfully submitted,
`
`
`
`
`Date: January 10, 2018
`
`
`Customer Number 24395
`Wilmer, Cutler, Pickering, Hale and Dorr, LLP
`Phone 202 663 6000
`
`
`
`
`
`
`
`/David L. Cavanaugh/
`David L. Cavanaugh
`Reg. No. 36,476
`
`ActiveUS 166123392v.1
`
`4
`
`
`
`Case IPR2018-00390
`Attorney Docket No: 2209539-00142
`
`
`
`CERTIFICATE OF SERVICE
`
`Pursuant to 37 CFR §§ 42.6(e)(4) and 42.205(b), the undersigned certifies
`
`that on January 10, 2018, a complete and entire copy of this Patent Owner Gilead
`
`Pharmasset LLC’s Mandatory Notices and Power of Attorney were provided via
`
`electronic service, to the Petitioner by serving the correspondence address of
`
`record as follows:
`
`Daniel B. Ravicher
`Ravicher Law Firm PLLC
`2000 Ponce De Leon Blvd Ste 600
`Coral Gables, FL 33134
`
`E-mail: dan@ravicher.com
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`/David L. Cavanaugh/
`
`David L. Cavanaugh, Reg. No. 36,476
`Wilmer Cutler Pickering Hale and Dorr LLP
`1875 Pennsylvania Avenue, N.W.
`
`Washington, DC 20006
`Phone: 202 663 6025
`
`
`
`
`
`
`
`
`
`ActiveUS 166123392v.1
`
`5
`
`